Synthetic Biologics proposes direct public offering

Synthetic Biologics Inc. (NYSE-M:SYN), Rockville, Md. Business: Infectious, Autoimmune, Gastrointestinal Date announced: 2014-10-10 Type: Direct public offering To be raised: $20.7 million Units: 14.1...